Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS outlines P4P

This article was originally published in The Gray Sheet

Executive Summary

CMS 1paper on value-based purchasing, released March 23, describes options to transition the current inpatient pay-for-reporting system to a pay-for-performance system in FY 2009, as mandated by the Deficit Reduction Act of 2005. The agency plans to make a percent of hospital inpatient payment updates conditional on providers meeting performance measures for heart failure, myocardial infarction and pneumonia, among other conditions. CMS says the program will not incorporate additional funding beyond the annual update. The paper will be discussed during a public listening session April 12. Comments are due April 19...

You may also be interested in...



Device Standardization Is Key In Value-Based Purchasing Environment – AHA

Device firms will need to further standardize their products as hospitals aim to meet new Medicare health care quality measures over the next few years, a hospital industry rep said April 25

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
UsernamePublicRestriction

Register

MT024637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel